Events

Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability

Dec 7, 2020 at 8:30 AM EST to Dec 7, 2020 at 12:00 AM EST